Elizabeth Nemchik

Elizabeth Nemchik, CPA, currently serves as the Financial Controller at Quanta Therapeutics since September 2023, following a role as a consultant at Imvax, Inc. in late 2023. Prior experience includes significant leadership positions as Financial Controller at Context Therapeutics, BioSpecifics Technologies Corp, and Verrica Pharmaceuticals, where key achievements involved enhancing financial operations, establishing internal controls, and preparing for public company transitions. Elizabeth's consultancy roles at Endo International plc and Galera Therapeutics, Inc. focused on accounting services and stock compensation implementations. With a strong foundation in finance from Villanova University, Elizabeth has a proven history of managing complex financial reporting processes and improving operational efficiencies across various organizations.